By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


American Association for Cancer Research 

615 Chestnut St.
17th Floor
Philadelphia  Pennsylvania  19106-3483  U.S.A.
Phone: 215-440-9300 Fax: 215-440-9313


Company News
Merrimack (MACK) Presents Expanded Analysis From Seribantumab (MM-121) Phase 2 Breast Cancer Study At The AACR Precision Medicine Series 5/18/2016 7:10:24 AM
MabVax Therapeutics' HuMab-5B1 Cancer Therapeutic Featured In Presentation At AACR Special Meeting On Pancreatic Cancer 5/16/2016 7:03:41 AM
TrovaGene (TROV) Release: Large Clinical Study Demonstrates High Detection Rate And Ability To Monitor KRAS Mutations In Pancreatic Cancer Patients; Results Presented At 2016 AACR Pancreatic Cancer Meeting 5/13/2016 7:33:09 AM
Provectus Reports Data On PV-10 In Combination Therapy And T Cell Mediated Immunity Presented At AACR Annual Meeting 2016 4/22/2016 9:14:11 AM
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016 8:31:50 AM
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016 8:28:45 AM
Merrimack (MACK) Unveils Its Latest Antibody Directed Nanotherapeutic, MM-310, At The 2016 AACR Annual Meeting 4/21/2016 6:30:05 AM
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR 4/21/2016 6:16:52 AM
Peregrine (PPHM) Release: Preclinical Data Presented At AACR Annual Meeting Demonstrate Enhanced Therapeutic Benefit Of Combining A Ps-Targeting Antibody With Anti-Pd-1 Therapy In Models Of Triple Negative Breast Cancer (TNBC) 4/20/2016 3:15:37 PM
AACR 2016 Research Shows Circulogene Theranostics Liquid Biopsy Excels At Real-Time Monitoring Of Cancer Mutations 4/20/2016 11:47:19 AM